Second 'Taishan Award' Ceremony Held in Shanghai, Honoring Eight Categories of Outstanding Contributors to China's Healthcare Sector

4Month10Day,“2021Medical Value-Based Healthcare Conference & The 2nd Taishan Award Ceremony”Held in Shanghai. The conference was attended by Dr. Wu Jinglei, Director of the Shanghai Municipal Health Commission; Academician Ge Junbo from Zhongshan Hospital, Fudan University; Professor Li Guangwei from Fuwai Hospital, Chinese Academy of Medical Sciences; Dr. Jin Chunlin, Director of the Shanghai Center for Health and Development Research; as well as over one hundred experts and scholars in the fields of healthcare, pharmaceuticals, and medical insurance, along with executives from pharmaceutical companies and innovative industry sectors. Conference Organizer“Medical Media”Founder,CEOChen Qirui introduced,“Taishan Award”Founded in2019year, its name is derived from“Health in Trust, Lives Entrusted: The Physician’s Responsibility Weighs Heavier than Mount Tai”meaning.

Director Wu Jinglei of the Shanghai Municipal Health Commission believes that,“Taishan Award” Drawing its name from the foremost of the Five Great Mountains, it supports the promotion of value-based healthcare in China from perspectives including public health, medical care, and management, perfectly embodying the importance of healthcare and health services.

“Value-based healthcare represents the most cost-effective medical services. From the perspective of clinicians, it is patient-centered, shifting focus from treating diseases to caring for individuals, thereby providing patients with dignified and health-oriented medical care.”Academician Ge Junbo said,“‘Taishan Award’Establishing a series of awards related to clinical practice, public health, healthcare management, philanthropy, media, and pharmaceuticals is the most effective way to drive all stakeholders toward achieving the concept of value-based healthcare, as well as the best approach to implementing it.” 

2021Annual“Taishan Award”Who Will Take the Crown?2021Annual“Taishan Award”A total of eight awards are presented, including the Clinical Research Award, Diagnosis and Treatment Protocol Award, Public Health Award, Healthcare Management Award, Public Welfare Figure Award, Medical Journalism Award, New Drug Breakthrough Award, and Corporate Contribution Award.  

Individual Awards: 

Annual Clinical Research Award：

Professor Liu Jianmin, Changhai Hospital Affiliated to Naval Medical UniversityGrant

Reason for Award：

Providing Stroke Treatment for the World“China Solution”

Liu Jianmin stated,“Taishan Award”can be awarded the Clinical Research Award“Efficacy Evaluation of Direct Endovascular Therapy for Acute Large Vessel Occlusion Ischemic Stroke in China (DIRECT-MT）”research team, is for Chinese cerebrovascular disease doctors in the past20Annual recognition of stroke prevention and control efforts. It took only one month from submission to publication of these research findings in the New England Journal of Medicine.“Our key takeaway from this study is that only by reaching parity with international standards can we truly identify cutting-edge global research questions. It is essential to design studies using internationally accepted high-standard protocols, ensure scientific rigor throughout the research process, and strictly adhere to these standards at every step. Ultimately, our findings gained international recognition.” 2017In [year], the country launched“The Million New Disability Reduction Project”. Professor Liu Jianmin said:“Stroke prevention and control remain a formidable challenge, requiring concerted efforts from the entire society.” 

Annual Public Health Award：

Professor Li Liming, School of Public Health, Peking UniversityGrant

Reason for Award：

Investigation50Tracing the Origins of Chronic Diseases in China Among 10,000 PeopleSource

“The goal of public health is to effectively prevent and control diseases, protect and promote people's health through the efforts of the entire society. Its scope includes the prevention and treatment of infectious diseases and chronic diseases, as well as lifecycle management of public health, among other areas. The core mission of public health is to develop public policies, relying on strong government leadership and the support of relevant laws and regulations. It is not merely a technical issue but also a social one, with its implementation encompassing all aspects of society—a fact that was clearly demonstrated during last year’s epidemic prevention and control efforts. We have seen that not only experts but also a vast number of grassroots workers played a pivotal role in these efforts. In the future, we should strengthen the integration of medical care and prevention, enhance multi-sectoral collaboration, integrate health into all policies, and establish a well-educated, multidisciplinary public health workforce to provide technical support and safeguards.”

Annual Healthcare Management Award：

Chen Haixiao, Director of Taizhou Enze Medical CenterRen

Reason for Award：

China's First“China National Quality Award”Award-Winning Hospital LeadersHuman

“What kind of healthcare do people expect? I believe it revolves around five core elements: quality, speed, cost, compassion, and dignity. These are also the most essential components of value-based healthcare. 2012In that year, we constructed high-standard infectious disease wards, equipped with over 100 fully negative-pressure rooms. It was precisely this preparedness that gave us strong confidence. At the very onset of the epidemic, we immediately proposed to the government that we could centrally treat all confirmed cases in Taizhou. Ultimately, our hospital treated the largest number of patients in Zhejiang Province, and all patients were cured and discharged. Taizhou Enze Medical Center, as a regional hospital, has been committed to building a high-quality clinical diagnosis and treatment system and a compassionate customer service system.2019During the Taizhou floods, the entire city suffered power and water outages, with only the lights of Taizhou Enze Hospital remaining on. In the face of this disaster, in addition to providing medical care, our hospital became a refuge where residents from across the city came to charge their devices. This, I believe, is what makes a hospital truly compassionate. "I believe that as long as we serve the people and continuously create value for them and for society, society will, in turn, recognize our contributions."” 

Annual Public Welfare Figure Award：

Director Wang Keqin of the Love Clearing Dust Public Welfare FoundationLong

Reason for Award：

Established China’s First Public Welfare Organization for Pneumoconiosis Patients, Providing Aid to Millions of Farmers with PneumoconiosisPeople

“Among all occupational diseases, pneumoconiosis accounts for90%, farmers account for the majority of pneumoconiosis patients90%, it can be said that pneumoconiosis is one of the most severe social and medical issues in China this century. The number of patients with pneumoconiosis is enormous, and their plight is tragic. From2011Year‘Love Clearing Dust’Since our founding, we have been assisting pneumoconiosis patients and their families through various means. Over the years, we have also been mobilizing deputies to the National People’s Congress to promote improvements in pneumoconiosis-related policies through formal proposals. Thanks to our relentless efforts, the state has attached increasing importance to the issue of pneumoconiosis and introduced many significant policies. I also hope that the state will further advance the implementation of policies to provide better medical and livelihood security for patients with pneumoconiosis.”  

Group Awards: 

Annual Clinical Treatment Plan Award：

China Chest Pain Center AllianceAlliance

Reason for Award：

11Carrying Forward the Spirit of Exploration and Struggle to Promote the Development of Chest Pain Centers in ChinaBureau

Professor Huo Yong, Chairman of the Chinese Chest Pain Center Alliance, attended the award ceremony and explained why China has established chest pain centers. “Past30In recent years, the incidence and mortality rates of cardiovascular and cerebrovascular diseases in China have risen rapidly. Although medical technology has advanced quickly, the vast majority of patients are unable to reach hospitals in time.2/3of myocardial infarction patients died outside the hospital. The establishment of Chest Pain Centers has reduced patient treatment time by30%...many, in-hospital mortality decreased by nearly50%。 To date, Chest Pain Centers have established a comprehensive set of standards covering training, accreditation, and quality control. They have also achieved effective coordination spanning from pre-hospital to post-hospital care, and from primary healthcare institutions to the general public. Currently, a nationwide network of Chest Pain Centers has been established across China, including in Qinghai Province, achieving100%provincial-level coverage,84%prefecture-level city coverage,77%county-level coverage. We have continuously deepened the development of Chest Pain Centers, establishing city-wide, county-wide, and district-wide models. In the future, we will form a system centered on medical institutions that integrates emergency care for diseases, chronic disease management, and health screening. We aim to build a novel prevention and control system for cardiovascular diseases, contributing to the Healthy China initiative.” 

Annual Medical Reporting Award：

Caixin Media’s Editorial Team for “How Did the Novel Coronavirus Come to This?”Team

Reason for Award：

To Leave the Best Record of Human Society During the COVID-19 PandemicRecord

 
Bao Zhiming, Deputy Director of the Technology News Department at Caixin, attended the ceremony to accept the award and shared the behind-the-scenes stories of the reporting. “At the outset of the epidemic outbreak, many of ourHumanAll voluntarily remained in Wuhan, hoping to provide the most professional coverage. SomeEvenWe are prepared for the possibility of no return. In Wuhan, we also witnessed many moving scenes. Many of the nurses on the front lines in Wuhan were very young. I still remember one girl who was97That year, when she opened her suitcase to retrieve items, there was a large teddy bear inside. Unaware of what lay ahead, she brought the stuffed animal with her to the front lines. During the fight against the epidemic in Wuhan, everyone made significant sacrifices. I believe that both medical professionals and media practitioners must fulfill their responsibilities to prevent similar tragedies from occurring in the future.” 

Annual New Drug Breakthrough Award：

Zanubrutinib CapsulesCyst

Reason for Award：

The First Chinese Anti-Cancer Drug Approved for Marketing in the United States, with a Complete Remission Rate as High as ___ in the Treatment of Mantle Cell Lymphoma78%

Mr. Wang Zhiwei, Senior Vice President of BeiGene, attended the ceremony to accept the award, stating:“When we initiated the zanubrutinib project, we focused on two key considerations: first, to achieve superior efficacy; and second, to ensure a higher safety profile. The underlying intent behind these two priorities was to provide patients with better therapeutic solutions. Approximately six months after the project was launched, the drug was developed and subsequently received U.S.FDABreakthrough Therapy Designation, approved in multiple countries, has also been successfully included in China’s National Reimbursement Drug List. BeiGene has been established.11years. In the next10In the coming year, we hope that through our collective efforts, China’s pharmaceutical industry will develop high-quality medicines that benefit not only Chinese people but also patients worldwide.” 

Annual Corporate Contribution Award：

Novartis Group

Award Citation：

The Foreign Pharmaceutical Company with the Most Products Included in the National Reimbursement Drug List in Recent YearsIndustry

Ms. Xu Yunlan, Vice President of Novartis Group (China), attended the award ceremony and stated:“The Taishan Award is an affirmation of our efforts over the past years and motivates us to do even better in the future. Beyond the joy of receiving this honor, two words come to mind:‘Innovation’and‘Accessibility’。

 Innovation plays a pivotal role in the development of the entire healthcare industry. In the past6year, Novartis has nearly in China30Approval of New Drugs and Indications. Future5In the year, we hope to achieve50applications for new drugs and indications. To2024In [year], we aim to surpass9China’s newly developed drugs can keep pace with global advancements—this is our commitment to innovation. Accessibility, which means ensuring that the general public can access and afford medications. In recent years, the Chinese government has continuously introduced favorable policies, and Novartis has actively participated by launching patient assistance programs. Novartis’s subsidiaries annually serve more than500provide high-quality, affordable medications to tens of thousands of patients. I believe this is where our value lies.”

In addition to presenting the awards for the 2nd Taishan Prize, conference participants engaged in extensive discussions through keynote speeches and roundtable panels on topics such as the definition and practice of value-based healthcare, the mission and prospects of public health systems in the new era, and the responsibilities and contributions of medical professionals. The event served as a feast of academic exchange. The conference was also broadcast via live streaming at“Medical Community Doctor Station”AppLive broadcast throughout the entire event. 

At this meeting,“Medical Media”Mr. Chen Qirui, the founder, together with Academician Ge Junbo, Professor Li Guangwei, and Director Sun Ningling, jointly launched the selection for the 3rd Taishan Award for Value-Based Healthcare.